Trial Profile
PDE5 Inhibition to Alleviate Functional Muscle Ischemia in Becker Muscular Dystrophy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Jul 2016
Price :
$35
*
At a glance
- Drugs Tadalafil (Primary)
- Indications Duchenne muscular dystrophy
- Focus Therapeutic Use
- 25 Jul 2016 Status changed from active, no longer recruiting to completed.
- 06 Aug 2014 New trial record